Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY27 defense appropriations and NDAA, requests to ensure adequate funding for such innovations to finalize development and distribution
2026 · 1st Quarter (Jan 1 - Mar 31)
KARDIOGENICS, INC.
Filed by TENAGRITY SOLUTIONS, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 20, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- TENAGRITY SOLUTIONS, LLC
- Client
- KARDIOGENICS, INC.
- Filing UUID
- 82e42638-c6f4-4ead-b40c-680467127585
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Discussions with congressional offices and HHS re: client and how their product and work could save lives
Discussions with congressional offices, HHS, and DoD re: client and how their product and work could save lives (including how they can help with defense)
Discussions with congressional offices and DoD re: client and how their product and work could save lives (including how they can help with defense); FY27 defense appropriations and NDAA, requests to ensure adequate funding for such innovations to finalize development and distribution
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.